Vous avez cherché: immunocompromised (Anglais - Slovène)

immunocompromised
imunsko okrnjen

immunocompromised children
imunsko ogroženi otroci

in severely immunocompromised individuals
humoralna ali celična (primarna ali pridobljena) imunska pomankljivost, vključno s hipogamaglobulinemijo, disgamaglobulinemijo in aidsom, simptomatska okužba z virusom hiv ali starostno specifični odstotek cd4+ t- limfocitov < 25% (glejte poglavje 4. 4).

immunocompromised subjects 21 days after
bolniki s kroničnimi bolezenskimi stanji

patients in a severely immunocompromised state
bolniki, ki so hudo imunsko oslabeli.

immunocompromised individuals (see section 4.3)
posamezniki z oslabljenim imunskim sistemom (glejte poglavje 4.3)

immunocompromised individuals (see section 4.3),
osebe s pomanjkljivo imunostjo (glejte poglavje 4.3),

imlygic has not been studied in immunocompromised patients.
zdravilo imlygic pri imunokompromitiranih bolnikih ni raziskano.

very limited data in immunocompromised patients are available for idflu.
na voljo je zelo malo podatkov o uporabi cepiva idflu pri imunokompromitiranih bolnikih.

<1,000 cells/mm3) or severely immunocompromised patients.
< 1.000 celic/mm3) ali zelo oslabljenim imunskim sistemom.

pimecrolimus cream should not be used in immunocompromised adults or children.
pimekrolimus v kremi se ne sme uporabljati pri odraslih ali otrocih z oslabljenim imunskim sistemom.

necrotizing retinitis has been reported post-marketing in immunocompromised individuals.
pri posameznikih z oslabljenim imunskim sistemom so v obdobju trženja zdravila poročali o nekrotizirajočem retinitisu.

in immunocompromised patients, repeat treatment with imiquimod cream is not recommended.
pri imunsko oslabljenih bolnikih ponavljanje zdravljenja z imikvimod kremo ni priporočljivo.

no clinical experience exists with the use of imiquimod cream in immunocompromised patients.
z uporabo imikvimod kreme pri imunsko kompromitiranih bolnikih kliničnih izkušenj ni.

patients who were immunocompromised and patients with severe neutropenia were excluded from clinical trials.
bolniki s hudo imunsko oslabelostjo in bolniki s hudo nevtropenijo niso bili vključeni v klinična preskušanja.

such patients may require additional doses of vaccine; nevertheless immunocompromised patients may fail
ti bolniki bodo morda potrebovali dodatne

immunisation using a live organism vaccine has the potential to cause infection in immunocompromised hosts.
pri bolnikih z oslabljenim imunskim sistemom lahko po cepljenju z živim cepivom pride do okužbe.

immunocompromised vaccinees (e.g. dialysis patients, transplant patients, aids patients)
imunsko kompromitirane cepljene osebe (npr. bolniki na dializi, bolniki po presaditvi, bolniki z aids- om)

parenterally administered anidulafungin was effective against candida species in immunocompetent and immunocompromised mouse and rabbit models.
pri imunokompetentnih in imunsko oslabelih miših in kuncih je bil parenteralno aplicirani anidulafungin učinkovit proti vrstam candidi spp.

32 following reconstitution of the immune system in immunocompromised patients with pml, stabilisation or improved outcome has been seen.
po ponovni vzpostavitvi imunskega sistema pri imunsko oslabljenih bolnikih s pml so opazili stabilizacijo ali izboljšanje izida.